Web13 nov. 2024 · An effective regimen including steroid (dexamethasone), methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) was developed by the NK-Cell Tumor Study Group as a unique chemotherapeutic regimen to combat chemo-resistant NK-cell neoplasms (Yamaguchi et al. 2008) and later shown to have efficacy in relapsed and … Web26 mrt. 2024 · The plan was sequential therapy with chemotherapy (modified SMILE regimen) followed by radiation therapy, the so called “sandwich” approach. The decision …
Prediction and prevention of central nervous system
Web25 okt. 2024 · Cohort 1: dexamethasone, methotrexate, ifosfamide, pegaspargase, and etoposide (modified SMILE) chemotherapy regimen alone and pembrolizumab in … WebChemotherapy drugs, such as treosulfan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fludarabine may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. rATG is used to decrease the body's immune response … customized christmas photo ornaments
Toxicity of a Modified Peg-Asparaginase-Based SMILE Regimen Is ...
Web30 apr. 2024 · The recent application of combined modality therapy with concurrent or sequential radiation therapy for early stage disease, along with non-anthracycline-based chemotherapy regimens consisting of drugs independent of P-glycoprotein have significantly improved clinical outcomes. Web9 aug. 2024 · The SMILE regimen was later modified as PIGLETS regimen (cisplatin, ifosfamide, gemcitabine, L-asparaginase, etoposide, dexamethasone) to reduce the risk … WebClinical details, outcome and safety of patients receiving mSMILE are described and most localized-stage patients achieved long-term disease control and most of the advanced … customized christmas postcards